News
NVS
138.72
-0.34%
-0.48
TG Therapeutics: What Wall Street Isn't Telling You
Seeking Alpha · 14h ago
Biogen: Competing With Eli Lilly's Kisunla, Safety Gives Market Edge
Seeking Alpha · 16h ago
2026 S&P 500 Outlook: Look For Pharma Sector To Lead The Way With Potential Changes
Seeking Alpha · 1d ago
Weekly Report: what happened at NVS last week (1222-1226)?
Weekly Report · 1d ago
Novartis: A Mispriced Hedge In A Crowded Equity Market
Seeking Alpha · 2d ago
Celcuity: After Stellar 2025, I Predict More Success In 2026 And Beyond
Seeking Alpha · 6d ago
Medicare pilot programs aim to reduce prescription drug spend
Seeking Alpha · 6d ago
Novartis AG (NOVN) Receives a Buy from J.P. Morgan
TipRanks · 12/24 03:15
MSFT, CRM, ORCL: Why Evercore Names These 3 Software Stocks as ‘Top Picks for 2026’
TipRanks · 12/23 15:16
Trump Trade: Trump strikes deals with nine drugmakers to cut prices
TipRanks · 12/22 15:25
US Medicaid Program Will Hit Swiss Wallets Hard, Roche CEO Says
Benzinga · 12/22 13:43
Government deals lift overhang on pharma group, says BofA
TipRanks · 12/22 12:21
Weekly Report: what happened at NVS last week (1215-1219)?
Weekly Report · 12/22 09:37
2 Top Stocks to Buy and Hold for the Long Term
The Motley Fool · 12/22 07:50
Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal
Benzinga · 12/20 06:38
Nine Major Drugmakers Agree To Lower Drug Prices Through TrumpRx Initiative
NASDAQ · 12/20 01:45
More Drugmakers Reach Deals With White House to Lower Prices
The Wall Street Journal · 12/19 21:09
Mirum Pharmaceuticals Sues Generic Drugmakers Over Livmarli Patent Infringement
Reuters · 12/19 21:07
Why Health Care ETFs Aren't Panicking Over Big Pharma's Price Cuts
Benzinga · 12/19 20:17
TRUMP: INSURANCE COMPANIES HAVE TO MAKE LESS MONEY
Reuters · 12/19 20:02
More
Webull provides a variety of real-time NVS stock news. You can receive the latest news about Novartis through multiple platforms. This information may help you make smarter investment decisions.
About NVS
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.